Search Results
Showing results 1 to 20 of 44.
News Release
FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis
August 14, 2019
Focus Area
Cannabis Research
Focus Area
Preventing Substance Use
RTI In The Media
FDA OKs 'Game Changer' Pretomanid for Highly Resistant TB
August 15, 2019 - Medscape
Expert
Archana Krovi
Insight
READDI Forethought uses the power of collaboration to accelerate scientific discovery
October 11, 2022
Expert
Sharon Daily
RTI In The Media
RTP-Based APIE Therapeutics, RTI Team Up to Develop Drug for Rare Lung Disease
August 26, 2020 - WRAL TechWire
News Release
RTI International Licenses Portfolio of Compounds to APIE Therapeutics
August 25, 2020
Expert
Sara Maloney Norcross
Expert
Nathan Vandergrift
Impact
New Drug Approved for Treatment of Extensively Drug-Resistant Tuberculosis
July 02, 2019
Impact
Implementing Clinical Trials for the Treatment of Long COVID
August 28, 2024
RTI In The Media
Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators
August 14, 2019 - The Telegraph
RTI In The Media
Triangle biotech startup aims to slow disease progression with RTI compounds
March 23, 2023 - WRAL TechWire
RTI In The Media
Breakthrough in Fight Against Multi-Resistant Tuberculosis
September 02, 2019 - Forbes
RTI In The Media
Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators
August 15, 2019 - Yahoo News UK
News Release
New Study Further Advances the Treatment of Chronic Pain
June 02, 2021
Expert
Daniela Cruz
Announcement
New Tuberculosis Treatment Recognized with Prix Galien Award
November 09, 2020